- 우선 이름
- Rapamycin Immunosuppressant Drug
- IUPAC
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- 현지명
- 2-아미노-2-데옥시갈락토스테트라키스(트리메틸실릴)유도체.
- 영어명
- 2-Amino-2-deoxygalactose tetrakis(trimethylsilyl)deriv.
- 분자식
- C51H79NO13
- 분자량
- 914.17186
이름 및 동의어
Rapamycin Immunosuppressant DrugRefChem:1097959Rapamycin (Sirolimus)C51H79NO13mTOR Inhibitor, RapamycinBDBM92863MSK10252sirolimus; 53123-88-9; C51H79NO13(1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone2-아미노-2-데옥시갈락토스테트라키스(트리메틸실릴)유도체.2-Amino-2-deoxygalactose tetrakis(trimethylsilyl)deriv.